By Shred Apps
Report updated May 20, 2026
GLP-1 Tracker: Pep
For individuals prescribed GLP-1 medications for weight loss who require a centralized tool for medication adherence, nutrition tracking, and progress monitoring.
GLP-1 Tracker: Pep is an established medical app that is free with in-app purchases. With a 4.6/5 rating from 2.3K reviews, it shows polarized user reception. Users particularly appreciate comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals, though inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss remains a common concern.
What is GLP-1 Tracker: Pep?
Pep is a medical tracking app for GLP-1 medication users, providing injection reminders, nutrition logging, and progress visualization on iOS and Android.
Users hire Pep to manage the high-stakes, multi-step requirements of GLP-1 treatment in one place, reducing the cognitive load of tracking medication, side effects, and nutrition simultaneously.
Current Momentum
v2.0 · 6d ago
Active- Added support for oral GLP-1 pills.
- Shipped performance optimizations for logging.
Active Nemesis
Medisafe Medication Management
By MediSafe
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Logs injectable and oral medication doses including Ozempic, Wegovy, Mounjaro, and Zepbound
Uses photo and barcode recognition to estimate calories, protein, and fiber via FatSecret API
Prompts users to alternate injection locations to prevent tissue damage
How much does it cost?
- Free version with core tracking features
- Premium membership for advanced tracking and insights
Freemium model uses a free-to-download entry point with a premium gate for advanced nutrition and progress analytics.
Who Built It?
Shred Apps
Providing specialized fitness and medical tracking tools tailored to specific user demographics and health journeys.
Portfolio
13
Apps
Who is Shred Apps?
Shred Apps, LLC utilizes a fragmented portfolio strategy, deploying gender-segregated and niche-specific applications rather than a single centralized platform. Their competitive advantage lies in securing expert-led content, such as tactical fitness programming from former Navy SEALs, and rapidly entering emerging health trends like GLP-1 medication tracking. The current trajectory shows a strategic expansion from general fitness into the medical-adjacent category, positioning the publisher to capture high-intent users in the weight management space.
Who is Shred Apps for?
- Diverse health-conscious segments
- Women seeking home-based routines
- Tactical fitness enthusiasts
- Individuals managing GLP-1 medication regimens
Portfolio momentum
The publisher maintains an intense development cadence with 30 releases across the portfolio in the last 6 months and a major release occurring within the last 14 days.
What other apps does Shred Apps make?
Stew Smith's Push-Up Push
Gym Workout Planner For Women
Navy SEAL Training & Exercises
Gym Workout For Men
Big Butt & Leg Workout Planner
Abs Workout – Men
What do users think recently?
Low confidence · Latest 64 of 112 total reviews analyzed · Based on 112 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals, but report inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for GLP-1 Tracker: Pep?
How's The Medical Market?
How does it evolve in the Medical market?
Pep currently holds a #64 Grossing position in the US Medical category. The gap between its utility-driven free user base and its grossing rank indicates that the premium gate for AI nutrition features is not yet converting at scale.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇫🇷 France | Medical | iOSGrossing | #42 | NEW |
| 🇺🇸 US | Medical | iOSGrossing | #93 | ▲1 |
The rivals identified
The Nemesis
- -
Weaker sentiment at 25/100 — but still a direct threat
- -
Integrates comprehensive drug-to-drug interaction warnings that go beyond simple shot reminders
- -
Supports family caregiver accounts allowing multiple users to manage a single patient's medication schedule
Contenders
Provides deep integration with external glucose monitoring hardware for automated data syncing
Offers a long-standing community forum for peer support which increases user stickiness
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡Dominates the diabetes logging space with a gamified UX that directly challenges the 'Pep' engagement model.
Utilizes gamification mechanics like challenges and point systems to drive daily logging consistency
Provides professional-grade PDF reports specifically formatted for endocrinologist consultations
Peers
Provides real-time pharmacy pricing comparisons that directly influence medication acquisition decisions
Offers a massive distribution network integrated into the pharmacy checkout experience
Proprietary data stream from continuous glucose monitors provides clinical-grade accuracy for users
Locked-in ecosystem ensures users remain within the Abbott digital environment for all health data
Hims: Telehealth for Men
★4.8 (85.2K)Hims & Hers
⚡Represents the vertical integration of telehealth and prescription fulfillment which is the ultimate destination for GLP-1 users.
Controls the entire value chain from initial provider consultation to direct-to-consumer medication delivery
Aggressive brand positioning focused on lifestyle and aesthetic outcomes rather than just medical tracking
New Kids on the Block
athenaPatient
★4.9 (133.9K)athenahealth
🚀Rapidly expanding patient portal with 5 releases in 6 months, signaling a push into mobile-first patient engagement.
Direct EHR integration allows patients to view clinical notes and lab results without manual entry
Standardized secure messaging with care teams replaces the need for separate symptom tracking apps
Spruce: Medical Communication
★4.9 (88K)Spruce Health
⚡High-velocity updates (12 releases in 6 months) indicate a focus on professional-grade patient-provider communication.
HIPAA-compliant video and messaging platform that bridges the gap between tracking and clinical advice
Enables providers to push custom care plans directly into the patient's mobile interface
The outtake for GLP-1 Tracker: Pep
Strengths to defend, gaps to attack
Core Strengths
- Centralized GLP-1-specific workflow reduces user cognitive load
- Injection site rotation tracking creates specialized health-safety switching costs
Critical Frictions
- AI meal scanner calorie variance poses health-safety risks
- Billing friction causes unauthorized charges
- Technical regressions in dosage logging erode trust
Growth Levers
- Integration with wearable devices would automate biometric data
- Expansion into professional-grade PDF reporting for endocrinologists
Market Threats
- Telehealth-integrated platforms like Hims capture the entire value chain
- Hardware-tethered apps like Libre by Abbott create high barriers to entry
What are the next best moves?
Ship manual override for AI food scanner
AI calorie inaccuracy is a top complaint, threatening user health-safety trust.
Trade-off: Pause the wearable integration sprint to prioritize core data accuracy.
Audit billing and cancellation flows
Unauthorized charge reports are rising, creating significant brand drag.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The reliance on AI food scanning is a strategic liability, not a differentiator, because the health-safety risk of inaccurate calorie tracking outweighs the convenience for the target medical audience.
Feature Gaps vs Competitors
- Clinical-grade drug-to-drug interaction warnings (available in Medisafe)
- Family caregiver accounts (available in Medisafe)
- Direct EHR integration (available in athenaPatient)
Key Takeaways
Pep succeeds by centralizing GLP-1 adherence, but technical instability and AI inaccuracy threaten its retention, so the PM must prioritize core data reliability over new feature expansion to stabilize the user base.
Where Is It Heading?
Mixed Signals
The GLP-1 tracking market is consolidating around tools that offer clinical-grade reliability, leaving Pep exposed to churn if its AI-driven features continue to underperform. The PM must pivot from feature-heavy updates to stability-first engineering to prevent users from migrating to more established medical-management platforms.
Technical regressions in the latest update break dosage logging, which directly erodes the daily habit and increases churn risk.
Recent updates focused on stability and oral pill support, indicating a shift toward maintaining core utility over aggressive feature expansion.